As shown in Figure 1A-1D, we have detected upregulated canonical Wnt activity relative to that observed in hMSCs, as evidenced by increased levels of active β-catenin, LEF1, TCF transcriptional activity and downstream target gene c-Myc in all bone sarcoma cell lines. This evidence concerns the gene HNF4A and bone sarcoma.